EP
SPRY icon

Eversept Partners’s ARS Pharmaceuticals SPRY Stock Holding History

Eversept Partners’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-48,788
Closed -$327K – 72
2023
Q2 		$327K Buy
+48,788
New +$327K 0.03% 65